Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice
fa-facebookfa-linkedinfa-youtube-playfa-rss

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: hospital

Litifilimab Promising for Cutaneous Lupus Erythematosus

Lara C. Pullen, PhD  |  April 10, 2023

A study found that litifilimab, a humanized monoclonal antibody that binds blood dendritic cell antigen 2, may be effective for the treatment of patients with active cutaneous lupus erythematosus. The treatment successfully reduced skin disease activity in patients at 16 weeks compared with placebo.

Filed under:ConditionsSystemic Lupus Erythematosus Tagged with:cutaneous lupus erythematosus (CLE)skinskin disease

A Medical Research Career Fueled by Curiosity

Gretchen Henkel  |  April 8, 2023

In January, Cecilia Pilar Chung, MD, MPH, began her new appointment as director of the Division of Rheumatology at the University of Miami. Previously, Dr. Chung was an associate professor of medicine at Vanderbilt University, Nashville, Tenn., for more than 10 years. At Vanderbilt, Dr. Chung built a strong research portfolio, focusing on the comparative…

Filed under:Professional TopicsProfiles Tagged with:Dr. Cecilia Chung

ACR Open Rheumatology Seeks New Editors

Deborah Levenson  |  April 8, 2023

As ACR Open Rheumatology (ACROR) enters its fifth year, its founding editors in chief are looking back on the journal’s accomplishments and forward to ushering in a new era, beginning with a search for their successors. Patricia Katz, PhD, professor of medicine and health policy at the University of California, San Francisco (UCSF), and Edward…

Filed under:Career DevelopmentProfessional Topics Tagged with:ACR Open Rheumatologyeditor

Research Update: Using Vagus Nerve Stimulation for Rheumatic Disease

Mary Beth Nierengarten  |  April 8, 2023

Over the past decade, a number of pilot studies have provided proof of concept for the use of vagus nerve stimulation (VNS) to treat rheumatic conditions. The studies represent an expansion of this treatment approach into rheumatology, building on years of scientific inquiry into the mechanisms of VNS on disease states that led to preclinical…

Filed under:ConditionsRheumatoid Arthritis Tagged with:RA Resource Centervagus nerve stimulation

Insights from a Neuro-Rheumatology Clinic

Kristin Galetta, MD, Shamik Bhattacharyya, MD, & Simon M. Helfgott, MD  |  April 7, 2023

Neuro-rheumatology is a fast-growing field. Better testing and imaging have increased recognition of once-infrequent diagnoses, such as neuro-sarcoidosis and amyloid beta-related angiitis. Concurrently, the rapid expansion of immunotherapy options to treat cancer and their untoward neurological side effects have increased the frequency of referrals to both neurologists and rheumatologists. Identifying and treating neurologic manifestations of…

Filed under:Practice Support Tagged with:collaborationCollaboration Initiativesinterdisciplinaryneuro-rheumatologyNeurology

Mark Cuban: Mixing Up the Pharmaceutical Landscape

Catherine Kolonko  |  April 7, 2023

The Mark Cuban Cost Plus Drug Co. (CPD) launched in January 2022 to distribute and home deliver prescribed generic medications to consumers. The Texas-based business seeks to reduce the prices of generic drugs by leapfrogging financial negotiators and going straight to drug companies for supply, according to a news release.1 “It’s crazy that medications are…

Filed under:Drug Updates Tagged with:pharmacy benefit managersprescription drug prices

Case Report: GPA or IgG4-Related Disease in an 11-Year-Old Girl?

Geoffrey E. Thiele, MD, & Sara Haro, MD  |  April 7, 2023

Granulomatosis with polyangiitis (GPA) is a type of anti-neutrophil cytoplasmic antibody (ANCA) associated small vessel vasculitis that typically affects the kidneys, lungs and sinuses.1 Due to an overlap in signs and symptoms, GPA may initially be difficult to distinguish from IgG4-related disease, another condition that can affect multiple tissues and has variable presentations. Further complicating…

Filed under:ConditionsOther Rheumatic ConditionsVasculitis Tagged with:AAV FocusRheumcase reportFellowsFellows ForumGPAgranulomatosis with polyangiitisIgG4 related disease

Tips to Alleviate Rheumatologist Burnout

Vanessa Caceres  |  April 7, 2023

Because rheumatology is a complex cognitive specialty, rheumatologists and rheumatology professionals often see patients repeatedly for acute and chronic problems. Although that may lead to close relationships with patients, it may also make the specialty more prone to burnout, says Peter Y. Hahn, MD, MBA, CEO of University of Michigan Health-West, Wyoming, Mich. “It can…

Filed under:Practice SupportProfessional TopicsWorkforce Tagged with:Advanced Practice Cliniciansburnoutnurse practitioner

Appreciative Rheumatology: Positivity Beyond Serologies

Bharat Kumar, MD, MME, FACP, FAAAAI, RhMSUS  |  April 7, 2023

Spam, spam, advertisement, spam … wait wait, what’s this? A small envelope, addressed from Maine. I wonder what this is about? Usually, when I get an envelope this size, it’s a letter from someone trying to sell me something or complain about something I have no control over. So imagine my surprise when I found…

Filed under:OpinionPatient PerspectivePractice SupportRheuminationsSpeak Out Rheum Tagged with:burnout

A Unique Partnership Gives the ACR a Voice in Insurance Legislation Development

Joseph Cantrell, JD  |  March 20, 2023

A recent meeting of the National Council of Insurance Legislators (NCOIL) featured discussions of many topics important to ACR members, including pharmacy benefit manager legislation, biomarker testing and transparency in the healthcare market.

Filed under:InsuranceLegislation & Advocacy Tagged with:healthcare price transparencyinsurancepartnershippharmacy benefit managers (PBMs)

  • « Previous Page
  • 1
  • …
  • 34
  • 35
  • 36
  • 37
  • 38
  • …
  • 323
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
fa-facebookfa-linkedinfa-youtube-playfa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences